NDC00517-5601-25: HYDROXYZINE HYDROCHLORIDE INJECT.
HYDROXYZINE HYDROCHLORIDE INJECT. Key specifications include administration: INTRAMUSCULAR, primary_container_type: VIAL, protective_storage_feature: SUBJECT TO DAMAGE BY FREEZING, pharmaceutical_vehicle_type: AQUEOUS, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 1.000 MILLILITERS. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-519-8897, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAMUSCULAR |
| primary_container_type | VIAL |
| protective_storage_feature | SUBJECT TO DAMAGE BY FREEZING |
| pharmaceutical_vehicle_type | AQUEOUS |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 1.000 MILLILITERS |
| active_medicament_medicinal_strength | 50.000 MILLIGRAMS HYDROXYZINE HYDROCHLORIDE PER MILLILITER |
| part_name_assigned_by_controlling_agency | HYDROXYZINE HYDROCHLORIDE INJECTION USP 50 MG PER ML 1 M 25S |
| american_hospital_formulary_service_classification_number | 282492 |
| NSN | 6505-01-519-8897 |
| ADMINISTRATION | INTRAMUSCULAR |
| PRIMARY CONTAINER CONTENT QUANTITY | 1.000 MILLILITERS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | VIAL |
| PROTECTIVE STORAGE FEATURE | SUBJECT TO DAMAGE BY FREEZING |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | HYDROXYZINE HYDROCHLORIDE INJECTION USP 50 MG PER ML 1 M 25S |
| PHARMACEUTICAL VEHICLE TYPE | AQUEOUS |
| AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER | 282492 |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 50.000 MILLIGRAMS HYDROXYZINE HYDROCHLORIDE PER MILLILITER |